ClinicalTrials.Veeva

Menu

Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations (ACERCA)

F

Fundación Senefro

Status

Completed

Conditions

ANEMIA

Study type

Observational

Funder types

Other

Identifiers

NCT01903148
SEN-AEE-2011-01

Details and patient eligibility

About

The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.

Enrollment

455 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis.
  • Patients starting anemia treatment (naïve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011).
  • Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients

Exclusion criteria

  • Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period.
  • Kidney transplant patients.

Trial contacts and locations

29

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems